Animal Life Sciences is a pharmaceutical and nutritional development company focused on commercializing treatments for PETS, capitalizing on cutting edge human testing and drug development from some of the largest research institutions in the world. Over $98 million ($34 million of grant funding) has gone towards the development of our robust drug development pipeline. Our product portfolio includes multiple therapeutic technologies developed at MD Anderson Cancer Center, the largest cancer treatment and research institute in the world, and Wake Forest University. Our strategy is to leverage the breakthrough advances in human drug development generated from MD Anderson and other research institutes, by applying them to veterinary medicine under the guidance of our leading experts. We also plan to utilize our scientific and clinical expertise to create a brand of scientifically engineered pet food products for pet owners around the world.